About Us

Panoptes is a privately held clinical stage biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria. More information


Management Team

Dr. Franz Obermayr and Dr. Stefan Sperl are founders of Panoptes. Before they became CEO and COO of the company, they gathered significant development experience in all areas of drug development. Together they have more than 40 years of experience in drug discovery and development. More information

image description